Get the Stockscreener App
11.39
0.53%
0.06
Keen Vision Acquisition Corp stock is traded at $11.39, with a volume of 292.
It is up +0.53% in the last 24 hours and up +0.71% over the past month.
Keen Vision Acquisition Corp is a blank check company.
See More
Previous Close:
$11.33
Open:
$11.385
24h Volume:
292
Relative Volume:
0.02
Market Cap:
$122.27M
Revenue:
-
Net Income/Loss:
$1.45M
P/E Ratio:
-15.84
EPS:
-0.7191
Net Cash Flow:
$-705.90K
1W Performance:
+0.18%
1M Performance:
+0.71%
6M Performance:
+3.55%
1Y Performance:
+7.45%
1-Day Range:
$11.38
$11.39
1-Week Range:
$11.33
$11.39
52-Week Range:
$10.61
$11.42
Keen Vision Acquisition Corp Stock (KVAC) Company Profile
Name
Keen Vision Acquisition Corp
Sector
Industry
Phone
(203) 609-1394
Address
37 GREENBRIAR DRIVE, SUMMIT
Compare KVAC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVAC
Keen Vision Acquisition Corp
|
11.39 | 122.27M | 0 | 1.45M | -705.90K | -0.7191 |
|
LION
Lionsgate Studios Corp
|
5.76 | 1.91B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.35 | 702.73M | 0 | 16.92M | -1.35M | 0.29 |
|
CCCM
Columbus Circle Capital Corp I
|
10.53 | 480.62M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.52 | 468.90M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.85 | 465.53M | 0 | 1.30M | 0 | 0.0301 |
Keen Vision Acquisition Corp Stock (KVAC) Latest News
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Large Growth in Short Interest - MarketBeat
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025 - GlobeNewswire
Toronto Dominion Bank Invests $304,000 in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 50.0% in May - MarketBeat
Polar Asset Management Partners Inc. Has $1.65 Million Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Toronto Dominion Bank Takes $304,000 Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Polar Asset Management Partners Inc. Sells 228,773 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVACWKeen Vision Acquisition Corp Latest Stock News & Market Updates - Stock Titan
Medera Showcased Positive Interim Data From First-in-Human - GlobeNewswire
Keen Vision Acquisition Corp. SEC 10-Q Report - TradingView
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress - GlobeNewswire
Boothbay Fund Management LLC Sells 52,370 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Up 33.3% in April - MarketBeat
AQR Arbitrage LLC Sells 230,549 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Berkley W R Corp Trims Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Quarry LP Lowers Stake in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 By Investing.com - Investing.com India
Keen Vision Acquisition extends merger deadline By Investing.com - Investing.com Canada
Spartan Fund Management Inc. Makes New Investment in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 - Investing.com
Keen Vision Acquisition extends merger deadline - Investing.com Australia
Medera to Go Public through Merger with KVAC - CHEManager
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 62.5% in March - MarketBeat
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of PLYA, LTRPA, MHLD, KVAC to Act Now - Morningstar
Yakira Capital Management Inc. Buys New Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.26 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.26 amid market optimism By Investing.com - Investing.com South Africa
Press Release Distribution & PR Platform - ACCESS Newswire
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Keen Vision Acquisition Corp Stock (KVAC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
4.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):